News and ViewsShort-Term Price Performance and Market Context
The stock has underperformed relative to its benchmark indices and sector peers in the immediate term. Over the past week, Aarey Drugs has declined by 3.53%, nearly double the Sensex’s 1.69% fall. The one-month performance shows a similar pattern, with the stock down 4.48% compared to the Sensex’s 1.92% decrease. Year-to-date, the stock has fallen 5.44%, significantly more than the benchmark’s 1.87% drop. This recent weakness contrasts with the stock’s longer-term strength, as it has delivered a 17.26% gain over the past year, outperforming the Sensex’s 9.56% rise, and even more impressively, a 121.07% return over five years compared to the Sensex’s 68.97%.
Technical Indicators and Trading Activity
